ArticlePharmaceutics2026

Synergistic Co-Delivery of siFGF2 and Doxorubicin via QTPlus Nanoparticles for Enhanced Breast Cancer Therapy.

Xiaohan Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.